Ongoing support throughout your weight loss journey
True irritation requiring product discontinuation presents as persistent burning or stinging lasting beyond application period, significant redness spreading beyond application zone or lasting multiple hours, swelling of eyelids or periorbital area, increased sensitivity making area uncomfortable to touch, or itching suggesting allergic response
Novo Nordisk "is on the cusp of evergreening its obesity franchise beyond Ozempic/Wegovy through new innovation (drugs like Amycretin, Cagri-Sema), which could see it drive towards a $1 trillion valuation," Pot said
Personalized protocol planning is considered in the context of your overall health plan, clinical eligibility, and long-term goals
Dose escalation in months two and three can temporarily reintroduce mild symptoms